Table 2

HLA-DRB1-DQA1-DQB1 and risk group genotypes among which either an increase or a decrease of the odds ratio was found to be statistically significant

DRB1-DQA1-DQB1 genotype	Risk group genotype	Patients (n = 322)		Controls (AFBAC) (n = 622)		OR	95% CI	p Value
DRB1-DQA1-DQB1 genotype	Risk group genotype	n	%	n	%	OR	95% CI	p Value
*By Fisher’s exact test.
†Haldane’s correction is used when odds ratios and 95% confidence intervals are calculated.
AFBAC, affected family based artificial controls; CI, confidence interval; OR, odds ratio.
0401-(03)-0301, 0401-(03)-0302	SS	15	4.7	1	0.2	30.34	4.20 to 121.91	8.7×10⁻⁷*
0401-(03)-0301, 0401-(03)-0301	SS	6	1.9	0	0	25.57†	3.13 to 208.73†	0.0015*
0401-(03)-0301, (14)-(01)-0503	SO	3	0.9	0	0	13.64†	1.52 to 122.53†	0.039*
0401-(03)-0301, (1/10)-(01)-0501	Ss	10	3.1	2	0.3	9.94	2.04 to 38.64	6.2×10⁻⁴*
0408-(03)-0301, (1/10)-(01)-0501	Ss	8	2.5	2	0.3	7.90	1.55 to 34.60	0.0038*
0408-(03)-0301, (11/12)-05-0301	Sp	4	1.2	1	0.2	7.81	0.83 to 83.87	0.049*
0401-(03)-0302, (1/10)-(01)-0501	Ss	39	12.1	13	2.1	6.46	3.27 to 12.95	<10⁻⁶
0401-(03)-0302, 0401-(03)-0302	SS	7	2.2	3	0.5	4.59	1.06 to 19.37	0.022*
0401-(03)-0302, 0404-(03)-0302	SS	7	2.2	3	0.5	4.59	1.06 to 19.37	0.022*
(1/10)-(01)-0501, (1301)-(01)-0603	sP	6	1.9	30	4.8	0.37	0.14 to 0.96	0.038
(15)-(01)-0602, (1301)-(01)-0603	pP	2	0.6	16	2.6	0.24	0.05 to 1.08	0.027*
(08)-(04)-04, (1301)-(01)-0603	pP	1	0.3	10	1.6	0.19	0.02 to 1.44	0.067*
(07)-0201-0303, (15)-(01)-0602	Pp	0	0	6	1.0	0.15†	0.02 to 1.20†	0.082*
(15)-(01)-0602, (1302)-(01)-0604	pP	0	0	7	1.1	0.13†	0.02 to 1.02†	0.054*
(03)-05-02, (1301)-(01)-0603	NP	0	0	8	1.3	0.11†	0.01 to 0.89†	0.035*
(03)-05-02, (1302)-(01)-0604	NP	0	0	8	1.3	0.11†	0.01 to 0.89†	0.035*